30.06.2014
- The European Medicine Agency (EMA) has recommended approval of Abasria, Eli Lilly's biosimilar version of Sanofi's insulin glargine sold as Lantus. This means that the French...
26.04.2013
- AbbVie reported slightly better than expected quarterly results on Friday, fueled by surging sales of its Humira treatment for rheumatoid arthritis. Sales of Humira, which accounts...
22.03.2013
- European regulators have recommended approval of two new multiple sclerosis pills from Biogen and Sanofi, both of which are expected to become major sellers. Friday's decision by...
21.01.2011
- Embracing Monoclonals - Modern manufacturing methods and analytical tools have developed to a level that enables assured production of highly similar monoclonal antibodies. In...
17.11.2010
- European regulators are expected to adopt a conservative stance this week when they set rules for allowing copies of antibody drugs, used to fight cancer, rheumatoid arthritis and...
